GSA Capital Partners’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Buy |
+99,922
| New | +$289K | 0.02% | 1278 |
|
|
2025
Q1 | – | Sell |
-148,533
| Closed | -$575K | – | 1901 |
|
|
2024
Q4 | $575K | Buy |
148,533
+41,125
| +38% | +$159K | 0.04% | 782 |
|
|
2024
Q3 | $704K | Buy |
107,408
+55,984
| +109% | +$367K | 0.05% | 682 |
|
|
2024
Q2 | $373K | Buy |
51,424
+22,362
| +77% | +$162K | 0.03% | 1147 |
|
|
2024
Q1 | $221K | Buy |
29,062
+3,830
| +15% | +$29.1K | 0.02% | 1364 |
|
|
2023
Q4 | $115K | Sell |
25,232
-63,981
| -72% | -$292K | 0.01% | 1384 |
|
|
2023
Q3 | $352K | Buy |
89,213
+33,392
| +60% | +$132K | 0.03% | 993 |
|
|
2023
Q2 | $175K | Buy |
55,821
+45,029
| +417% | +$141K | 0.02% | 1307 |
|
|
2023
Q1 | $49K | Buy |
+10,792
| New | +$49K | ﹤0.01% | 1400 |
|
|
2019
Q3 | – | Sell |
-881
| Closed | -$13K | – | 1564 |
|
|
2019
Q2 | $13K | Sell |
881
-1,367
| -61% | -$20.2K | ﹤0.01% | 1396 |
|
|
2019
Q1 | $74K | Sell |
2,248
-3,501
| -61% | -$115K | 0.01% | 1351 |
|
|
2018
Q4 | $341K | Buy |
+5,749
| New | +$341K | 0.04% | 765 |
|
|
2017
Q3 | – | Sell |
-6,142
| Closed | -$259K | – | 1780 |
|
|
2017
Q2 | $259K | Buy |
+6,142
| New | +$259K | 0.02% | 1363 |
|